TwoStep Therapeutics
San Carlos, US · Founded 2023 · Delaware corporation · 4 known investors
TwoStep Therapeutics is a Stanford spinout developing targeted cancer therapies, including peptide-based drug conjugates and radioligand programs built on a tumor-targeting peptide platform. The company is advancing a preclinical pipeline toward a first clinical trial planned for the second half of 2026.
Founders & leadership
MP
Matias Porras PaniaguaDirector
CM
Caitlyn MillerCEO & Co-Founder
OA
Omri Amirav-DroryDirector
JP
John PrufetaDirector
JC
Jennifer CochranCo-Founder
CB
Carolyn BertozziCo-Founder
RL
Ronald LevyCo-Founder
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$21.1MraisedJan 2026 · 8 investors · OtherRule 506(b)
▶$21.1MraisedJan 2026 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matias Porras PaniaguaDirector
- Caitlyn MillerExecutive Officer, Director, Promoter
- Omri Amirav-DroryDirector
- John PrufetaDirector
- Offering amount
- $62.2M
- Amount sold
- $21.1M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$6.5MraisedMar 2024 · 6 investors · OtherRule 506(b)
▶$6.5MraisedMar 2024 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Caitlyn MillerExecutive Officer, Director, Promoter
- Omri Amirav-DroryDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.